Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Tarrabain Alex, Chief Financial Officer. Director active across 1 company, notably CEN Biotech INC. In total, 2 reports have been recorded. Activity tracked since 16 January 2021. The latest transaction was disclosed on 25 June 2021 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations
Alex Tarrabain is the Chief Financial Officer of CEN BIOTECH INC. He oversees the financial operations of the company, including financial planning and risk management, playing an essential role in CEN BIOTECH's financial strategy.